ERGIC3 Antikörper (N-Term)
Kurzübersicht für ERGIC3 Antikörper (N-Term) (ABIN952105)
Target
Alle ERGIC3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-30, N-Term
-
Spezifität
- This antibody recognizes Human ERGIC3 (N-term).
-
Aufreinigung
- Affinity Chromatography on Protein A
-
Immunogen
- KLH conjugated synthetic peptide between 1~30 amino acids from the N-terminal region of Human ERGIC3
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- ERGIC3 (ERGIC and Golgi 3 (ERGIC3))
-
Andere Bezeichnung
- ERGIC3
-
Hintergrund
- ERGIC3 is possible role in transport between endoplasmic reticulum and Golgi.Synonyms: C20orf47, CGI-54, ERV46, Endoplasmic reticulum-Golgi intermediate compartment protein 3, NY-BR-84, PRO0989, SDBCAG84, Serologically defined breast cancer antigen NY-BR-84
-
Molekulargewicht
- 43222 Da
-
Gen-ID
- 51614
-
NCBI Accession
- NP_057050
Target
-